Pramipexole — Non-ergot dopamine agonist. Study the mechanism, listed uses and warnings from the US label on one sourced card.
Generic name
Pramipexole
Class
Non-ergot dopamine agonist
Mechanism
Non-ergot dopamine agonist with in-vitro activity at D2-family receptors and greater affinity for D3 than D2 or D4. The precise mechanisms in Parkinson disease and restless legs syndrome are unknown.
Used for
Parkinson disease in adults; Moderate-to-severe primary restless legs syndrome in adults
Label date: 20260909 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Non-ergoline dopamine agonist thought to act by stimulating D2 receptors in the caudate-putamen.
On both cards: Common side effects — Nausea; Dizziness; Somnolence; Hallucinations · Warnings — Falling asleep during daily activities; Impulse control / compulsive behaviors
Only on the Ropinirole card: Used for — Parkinson's disease; Moderate-to-severe primary restless legs syndrome · Common side effects — Syncope · Warnings — Orthostatic hypotension / syncope · Interactions — CYP1A2 inhibitors or inducers; Hormone replacement therapy; Dopamine antagonists
Mechanism: Activity is mainly mediated by MHD. The precise anti-seizure mechanism is unknown; in-vitro studies indicate voltage-sensitive sodium-channel blockade that stabilizes hyperexcited membranes.
On both cards: Common side effects — Nausea; Dizziness; Somnolence
Only on the Oxcarbazepine card: Used for — Partial-onset seizures: monotherapy or adjunctive treatment in adults; Partial-onset seizures: monotherapy in children aged 4 years and older; Partial-onset seizures: adjunctive treatment in children aged 2 years and older · Common side effects — Diplopia; Fatigue · Warnings — Hyponatremia; Serious dermatological reactions; Cross-hypersensitivity to carbamazepine · Interactions — Phenytoin; Strong CYP inducers (e.g., carbamazepine); Hormonal contraceptives
Mechanism: The exact analgesic and antiepileptic mechanisms are unknown. Gabapentin is structurally related to GABA but does not affect its binding, uptake or degradation. It binds the alpha-2-delta calcium-channel subunit in vitro; the relevance to therapeutic effects is unknown.
On both cards: Common side effects — Dizziness; Somnolence
Only on the Gabapentin card: Used for — Postherpetic neuralgia in adults; Adjunctive treatment of partial-onset seizures in adults and children aged 3 or older · Common side effects — Peripheral edema; Ataxia; Fatigue · Warnings — DRESS (multiorgan hypersensitivity); Respiratory depression with CNS depressants; Suicidal behavior and ideation · Interactions — Opioids; Antacids (aluminum/magnesium hydroxide)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera